CAR T-cell therapy was safe and effective in a DLBCL patient with coexisting autoimmune neuropathy. CD19 CAR T-cell therapy may control refractory autoantibodies and monoclonal gammopathies.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724903 | PMC |
| http://dx.doi.org/10.1182/bloodadvances.2020003176 | DOI Listing |
Publication Analysis
Top Keywords
coexisting autoimmune
8
autoimmune neuropathy
8
car t-cell
8
t-cell therapy
8
safety efficacy
4
efficacy car
4
car cells
4
cells patient
4
patient lymphoma
4
lymphoma coexisting
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!